An operator and manager at a dental clinic have been charged for their roles in a health care fraud scheme involving $6 million in claims to Medicaid, announced U.S. Attorney Jennifer B. Lowery.
Attorney General Lawrence Wasden announced Idaho joined 49 other states, Washington, D.C., Puerto Rico, and the federal government to settle allegations of fraud against Mallinckrodt ARD, LLC (formerly known as Questcor Pharmaceuticals, Inc.).
In a recent statement, the U.S. Department of Health and Human Services (HHS) announced nearly $60 million in investments to help rural communities get better access quality healthcare.
The Centers for Medicare & Medicaid Services yesterday proposed requiring states to report certain quality measures for children, adults and home health services in Medicaid and the Children’s Health Insurance Program beginning in federal fiscal year 2024. Currently, states may choose not to report the measures.
The Centers for Medicare & Medicaid Services yesterday released fact sheets summarizing the current status of Medicare COVID-19 blanket waivers and flexibilities by provider type, as well as flexibilities applicable to the Medicaid community.
In a lookback study of prescribing patterns among thousands of American ophthalmologists and optometrists, Johns Hopkins Medicine researchers concluded that eye doctors who receive even small financial incentives from pharmaceutical companies, such as free food, sponsored travel to attend meetings or consulting fees, are up to twice as likely to prescribe the companies’ brand name eyedrops for glaucoma instead of cheaper generic versions.